Efficacy of intravitreal Aflibercept in patients with neovascular AMD who were previously treated with Ranibizumab based on a Treat and Extend protocol

被引：0
|
作者：
Turksever, C.
Prunte, C.
Hatz, K.
机构：
来源：
ACTA OPHTHALMOLOGICA | 2015年 / 93卷
关键词：
D O I：
10.1111/j.1755-3768.2015.0396
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
ABS15-0396
引用
收藏
页数：3
相关论文
共 50 条
  • [31] A PROSPECTIVE, OPEN-LABEL STUDY TO ASSESS THE EFFECT OF AFLIBERCEPT ON ANATOMIC AND VISUAL OUTCOMES FOR PATIENTS WITH PERSISTENT BUT STABLE FLUID ON OCT SECONDARY TO NEOVASCULAR AMD PREVIOUSLY TREATED WITH RANIBIZUMAB
    Verma, Nitin
    Hewitt, Alex
    Bylsma, Guy
    Traill, Andrew
    Curry, Beverley
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 44 : 135 - 135
  • [32] Two-year outcomes of intravitreal aflibercept in a Swiss routine treat and extend regimen for patients with neovascular age-related macular degeneration
    Andreas Ebneter
    Stephan Michels
    Christian Pruente
    Pascal Imesch
    Felix Eilenberger
    Susanne Oesch
    Isabelle P. Thomet-Hunziker
    Katja Hatz
    Scientific Reports, 10
  • [33] Two-year outcomes of intravitreal aflibercept in a Swiss routine treat and extend regimen for patients with neovascular age-related macular degeneration
    Ebneter, Andreas
    Michels, Stephan
    Pruente, Christian
    Imesch, Pascal
    Eilenberger, Felix
    Oesch, Susanne
    Thomet-Hunziker, Isabelle P.
    Hatz, Katja
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [34] EFFICACY OF INTRAVITREAL AFLIBERCEPT ADMINISTERED USING TREAT-AND-EXTEND REGIMEN OVER 2 YEARS IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: BASELINE CHARACTERISTICS OF ARIES
    Mitchell, Paul A. O.
    Souied, Eric
    Midena, Edoardo
    Holz, Frank G.
    Hykin, Philip
    Wolf, Sebastian
    Allmeier, Helmut
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 : 129 - 129
  • [35] Efficacy of a Treat-and-Extend Regimen With Ranibizumab in Patients With Neovascular Age-Related Macular Disease A Randomized Clinical Trial
    Kertes, Peter J.
    Galic, Ivan J.
    Greve, Mark
    Williams, Geoff
    Baker, Jason
    Lahaie, Marcel
    Sheidow, Tom
    JAMA OPHTHALMOLOGY, 2020, 138 (03) : 244 - 250
  • [36] Intraocular pressure changes during intravitreal aflibercept injection based on treat-and-extend regimen in Japanese patients with neovascular age-related macular degeneration and glaucoma
    Honjo, Junichiro
    Mukai, Ryo
    Itagaki, Kanako
    Tanaka, Keiichiro
    Norikawa, Koki
    Kato, Yutaka
    Kasai, Akihito
    Sugano, Yukinori
    Sekiryu, Tetsuju
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2024, 68 (02) : 91 - 95
  • [37] A Phase III b, Multicenter Study of the Efficacy and Safety of Aflibercept Switch in Patients With Exudative AMD With Retinal Pigment Epithelium Detachment, Previously Treated With Ranibizumab Intravitreal Injections. The ARI2 Study.
    Blanco-Garavito, Rocio
    Jung, Camille
    Uzzan, Joel
    Coscas, Florence
    Quaranta El-Maftouhi, Maddalena
    Sahel, Jose
    Korobelnik, Jean-Francois
    Hera, Ruxandra
    Querques, Giuseppe
    Semoun, Oudy
    Souied, Eric H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [38] Intraocular pressure changes during intravitreal aflibercept injection based on treat-and-extend regimen in Japanese patients with neovascular age-related macular degeneration and glaucoma
    Junichiro Honjo
    Ryo Mukai
    Kanako Itagaki
    Keiichiro Tanaka
    Koki Norikawa
    Yutaka Kato
    Akihito Kasai
    Yukinori Sugano
    Tetsuju Sekiryu
    Japanese Journal of Ophthalmology, 2024, 68 : 91 - 95
  • [39] EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION The ARIES Study: A Randomized Clinical Trial
    Mitchell, Paul
    Holz, Frank G.
    Hykin, Philip
    Midena, Edoardo
    Souied, Eric
    Allmeier, Helmut
    Lambrou, George
    Schmelter, Thomas
    Wolf, Sebastian
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (09): : 1911 - 1920
  • [40] Switching to Intravitreal Brolucizumab after Ranibizumab or Aflibercept Using Treat and Extend Regimen for Neovascular Age-Related Macular Degeneration in Japanese Patients: 1-Year Results and Factors Associated with Treatment Responsiveness
    Hirayama, Kumiko
    Yamamoto, Manabu
    Honda, Shigeru
    Kyo, Akika
    Misawa, Norihiko
    Kohno, Takeya
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
12345